Long-term persistence of limited htlv-i tax-specific cytotoxic T cell clones in a patient with adult t cell leukemia/lymphoma after allogeneic stem cell transplantation

Journal of Clinical Immunology

Volumn 32, Issue 6, 2012, Pages 1340-1352

  Tanaka, Yukie ^a   Nakasone, Hideki ^a   Yamazaki, Rie ^a   Wada, Hidenori ^a   Ishihara, Yuko ^a   Kawamura, Koji ^a   Sakamoto, Kana ^a   Ashizawa, Masahiro ^a   Machishima, Tomohito ^a   Sato, Miki ^a   Terasako, Kiriko ^a   Kimura, Shun Ichi ^a   Kikuchi, Misato ^a   Okuda, Shinya ^a   Kako, Shinichi ^a   Kanda, Junya ^a   Tanihara, Aki ^a   Nishida, Junji ^a   Kanda, Yoshinobu ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Adult T cell leukemia lymphoma; cytotoxic T cell; human T cell lymphotropic virus type 1; T cell receptor repertoire; tax

Indexed keywords

CD27 ANTIGEN; CD28 ANTIGEN; CD57 ANTIGEN; T LYMPHOCYTE RECEPTOR; TAX PROTEIN; LEUKOCYTE ANTIGEN;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CASE REPORT; CELL CLONING; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MALE; PHENOTYPE; PRIORITY JOURNAL; T CELL LEUKEMIA; T CELL LYMPHOMA; VIRUS LOAD; VIRUS REPLICATION; BONE MARROW CELL; CELL CLONE; GENETICS; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; IMMUNOPHENOTYPING; MIDDLE AGED; PATHOLOGY; SINGLE CELL ANALYSIS;

ANTIGENS, CD; BONE MARROW CELLS; CLONE CELLS; GENE PRODUCTS, TAX; GRAFT VS HOST DISEASE; GRAFT VS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MALE; MIDDLE AGED; SINGLE-CELL ANALYSIS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84878255311     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-012-9729-5     Document Type: Article

References (44)

1. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50(3):481-92.
2. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980;77(12):7415-9.
3. Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita KI, et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci U S A. 1981;78(10):6476-80.
4. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A. 1982;79(6):2031-5.
5. Utsunomiya A, Miyazaki Y, Takatsuka Y, Hanada S, Uozumi K, Yashiki S, et al. Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001;27(1):15-20.
6. Kami M, Hamaki T, Miyakoshi S, Murashige N, Kanda Y, Tanosaki R, et al. Allogeneic haematopoietic stem cell transplantation for the treatment of adult T-cell leukaemia/lymphoma. Br J Haematol. 2003;120(2):304-9.
7. Okamura J, Utsunomiya A, Tanosaki R, Uike N, Sonoda S, Kannagi M, et al. Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma. Blood. 2005;105(10):4143-5.
8. Shiratori S, Yasumoto A, Tanaka J, Shigematsu A, Yamamoto S, Nishio M, et al. A retrospective analysis of allogeneic hematopoietic stem cell transplantation for adult T cell leukemia/lymphoma (ATL): clinical impact of graft-versus-leukemia/lymphoma effect. Biol Blood Marrow Transplant. 2008;14(7):817-23.
9. Kato K, Kanda Y, Eto T, Muta T, Gondo H, Taniguchi S, et al. Allogeneic bone marrow transplantation from unrelated human T-cell leukemia virus-I-negative donors for adult T-cell leukemia/lymphoma: retrospective analysis of data from the Japan Marrow Donor Program. Biol Blood Marrow Transplant. 2007;13(1):90-9.
10. Kannagi M, Shida H, Igarashi H, Kuruma K, Murai H, Aono Y, et al. Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells. J Virol. 1992;66(5):2928-33.
11. Pique C, Connan F, Levilain JP, Choppin J, Dokhelar MC. Among all human T-cell leukemia virus type 1 proteins, tax, polymerase, and envelope proteins are predicted as preferential targets for the HLA-A2-restricted cytotoxic T-cell response. J Virol. 1996;70(8):4919-26.
12. Kannagi M, Sugamura K, Kinoshita K, Uchino H, Hinuma Y. Specific cytolysis of fresh tumor cells by an autologous killer T cell line derived from an adult T cell leukemia/lymphoma patient. J Immunol. 1984;133(2):1037-41.
13. Jacobson S, Shida H, McFarlin DE, Fauci AS, Koenig S. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature. 1990;348(6298):245-8.
14. Arnulf B, Thorel M, Poirot Y, Tamouza R, Boulanger E, Jaccard A, et al. Loss of the ex vivo but not the reinducible CD8+ T-cell response to Tax in human T-cell leukemia virus type 1-infected patients with adult T-cell leukemia/lymphoma. Leukemia. 2004;18(1):126-32.
15. Harashima N, Kurihara K, Utsunomiya A, Tanosaki R, Hanabuchi S, Masuda M, et al. Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation. Cancer Res. 2004;64(1):391-9.
16. Tanaka Y, Nakasone H, Yamazaki R, Sato K, Sato M, Terasako K, et al. Single-cell analysis of T-cell receptor repertoire of HTLV-1 Tax-specific cytotoxic T cells in allogeneic transplant recipients with adult T-cell leukemia/lymphoma. Cancer Res. 2010;70(15):6181-92.
17. Letsch A, Keilholz U, Assfalg G, Mailander V, Thiel E, Scheibenbogen C. Bone marrow contains melanoma-reactive CD8+ effector T cells and, compared with peripheral blood, enriched numbers of melanoma-reactive CD8+ memory T cells. Cancer Res. 2003;63(17):5582-6.
18. Murao A, Oka Y, Tsuboi A, Elisseeva OA, Tanaka-Harada Y, Fujiki F, et al. High frequencies of less differentiated and more proliferative WT1-specific CD8+ T cells in bone marrow in tumor-bearing patients: an important role of bone marrow as a secondary lymphoid organ. Canc Sci. 2010;101(4):848-54.
19. Zhang X, Dong H, Lin W, Voss S, Hinkley L, Westergren M, et al. Human bone marrow: a reservoir for "enhanced effector memory" CD8+ T cells with potent recall function. J Immunol. 2006;177(10):6730-7.
20. Palendira U, Chinn R, Raza W, Piper K, Pratt G, Machado L, et al. Selective accumulation of virus-specific CD8+ T cells with unique homing phenotype within the human bone marrow. Blood. 2008;112(8):3293-302.
21. Letsch A, Knoedler M, Na IK, Kern F, Asemissen AM, Keilholz U, et al. CMV-specific central memory T cells reside in bone marrow. Eur J Immunol. 2007;37(11):3063-8.
22. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999;401(6754):708-12.
23. Appay V, Dunbar PR, Callan M, Klenerman P, Gillespie GM, Papagno L, et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med. 2002;8(4):379-85.
24. Focosi D, Bestagno M, Burrone O, Petrini M. CD57+ T lymphocytes and functional immune deficiency. J Leukoc Biol. 2010;87(1):107-16.
25. Wood KL, Twigg 3rd HL, Doseff AI. Dysregulation of CD8+ lymphocyte apoptosis, chronic disease, and immune regulation. Front Biosci. 2009;14:3771-81.
26. Hoji A, Connolly NC, Buchanan WG, Rinaldo Jr CR. CD27 and CD57 expression reveals atypical differentiation of human immunodeficiency virus type 1-specific memory CD8+ T cells. Clin Vaccine Immunol. 2007;14(1):74-80.
27. Betts MR, Brenchley JM, Price DA, De Rosa SC, Douek DC, Roederer M, et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods. 2003;281(1-2):65-78.
28. Di Rosa F, Santoni A. Bone marrow CD8 T cells are in a different activation state than those in lymphoid periphery. Eur J Immunol. 2002;32(7):1873-80.
29. Hermesh T, Moltedo B, Moran TM, Lopez CB. Antiviral instruction of bone marrow leukocytes during respiratory viral infections. Cell Host Microbe. 2010;7(5):343-53.
30. Grant C, Barmak K, Alefantis T, Yao J, Jacobson S, Wigdahl B. Human T cell leukemia virus type I and neurologic disease: events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation. J Cell Physiol. 2002;190(2):133-59.
31. Feuer G, Fraser JK, Zack JA, Lee F, Feuer R, Chen IS. Human T-cell leukemia virus infection of human hematopoietic progenitor cells: maintenance of virus infection during differentiation in vitro and in vivo. J Virol. 1996;70(6):4038-44.
32. Takamori A, Hasegawa A, Utsunomiya A, Maeda Y, Yamano Y, Masuda M, et al. Functional impairment of Tax-specific but not cytomegalovirus-specific CD8+ T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers. Retrovirology. 2011;8:100.
33. Johnson-Nauroth JM, Graber J, Yao K, Jacobson S, Calabresi PA. Memory lineage relationships in HTLV-1-specific CD8+ cytotoxic T cells. J Neuroimmunol. 2006;176(1-2):115-24.
34. Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med. 1996;184(3):1101-9.
35. Brouty-Boye D, Doucet C, Clay D, Le Bousse-Kerdiles MC, Lampidis TJ, Azzarone B. Phenotypic diversity in human fibroblasts from myelometaplasic and non-myelometaplasic hematopoietic tissues. Int J Cancer. 1998;76(5):767-73.
36. Sabouri AH, Usuku K, Hayashi D, Izumo S, Ohara Y, Osame M, et al. Impaired function of human T-lymphotropic virus type 1 (HTLV-1)-specific CD8+ T cells in HTLV-1-associated neurologic disease. Blood. 2008;112(6):2411-20.
37. Barbour JD, Ndhlovu LC, Xuan Tan Q, Ho T, Epling L, Bredt BM. High CD8+ T cell activation marks a less differentiated HIV-1 specific CD8+ T cell response that is not altered by suppression of viral replication. PLoS One. 2009;4(2):e4408.
38. Makadzange AT, Gillespie G, Dong T, Kiama P, Bwayo J, Kimani J, et al. Characterization of an HLA-C-restricted CTL response in chronic HIV infection. Eur J Immunol. 2010;40(4):1036-41.
39. Greten TF, Slansky JE, Kubota R, Soldan SS, Jaffee EM, Leist TP, et al. Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients. Proc Natl Acad Sci U S A. 1998;95(13):7568-73.
40. Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, Sharpe AH, et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. 2006;439(7077):682-7.
41. Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, Reddy S, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature. 2006;443(7109):350-4.
42. Bangham CR. CTL quality and the control of human retroviral infections. Eur J Immunol. 2009;39(7):1700-12.
43. Zafiropoulos A, Barnes E, Piggott C, Klenerman P. Analysis of 'driver' and 'passenger' CD8+ T-cell responses against variable viruses. Proc Biol Sci. 2004;271 Suppl 3:S53-6.
44. Asquith B, Bangham CR. How does HTLV-I persist despite a strong cell-mediated immune response? Trends Immunol. 2008;29(1):4-11.